Literature DB >> 178429

Urinary excretion of cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate in rats bearing transplantable liver and kidney tumors.

W E Criss, F Murad.   

Abstract

Cyclic guanosine 3':5'-monophosphate (cyclic GMP) and cyclic adenosine 3':5-monophosphate were measured in the urine of normal rats and those bearing transplantable liver and kidney tumors. The level of cyclic GMP ranged from 1.4 to 1.6 mumoles/g urinary creatinine in several strains of rats without tumors. Rats bearing Morris hepatomas 20, 21, 9618A and 9633F and kidney tumor MK2 had urine levels of cyclic GMP from 1.3 to 3.6 mumoles/g creatinine. Rats bearing the fast growing hepatomas 9618A2 and 3924A and Morris kidney tumor MK3 had urinary values of 5.6. 41.9, and 32.7 mumoles cyclic GMP per g creatinine, respectively. Urine levels of cyclic adenosine 3':5'-monophosphate ranged from 10.1 to 19.7 mumoles/g creatinine in all normal and tumor-bearing rats and were not significantly different in any of the groups examined.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178429

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy.

Authors:  C Gennari; G Francini; M Galli; F Lore
Journal:  J Clin Pathol       Date:  1978-08       Impact factor: 3.411

2.  Plasma and urine cyclic nucleotide levels in malignant disease and cirrhosis of the liver.

Authors:  P J Wood; G Ross; C L Smith
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

3.  Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma.

Authors:  Haifeng Zhu; Jessica Tao Li; Fang Zheng; Emil Martin; Alexander Y Kots; Joshua S Krumenacker; Byung-Kwon Choi; Ian E McCutcheon; Norman Weisbrodt; Oliver Bögler; Ferid Murad; Ka Bian
Journal:  Mol Pharmacol       Date:  2011-09-09       Impact factor: 4.436

4.  Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment.

Authors:  G A Turner; R D Ellis; D Guthrie; A L Latner; J M Monaghan; W M Ross; A W Skillen; R G Wilson
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

Review 5.  Hepatocellular carcinoma: Review of disease and tumor biomarkers.

Authors:  Jin Un Kim; Mohamed I F Shariff; Mary M E Crossey; Maria Gomez-Romero; Elaine Holmes; I Jane Cox; Haddy K S Fye; Ramou Njie; Simon D Taylor-Robinson
Journal:  World J Hepatol       Date:  2016-04-08

Review 6.  Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers.

Authors:  Francesca M Trovato; Joshua M Tognarelli; Mary Me Crossey; Daniela Catalano; Simon D Taylor-Robinson; Guglielmo M Trovato
Journal:  World J Hepatol       Date:  2015-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.